Sulfasalazine and Revlimid drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 140 people who take Sulfasalazine and Revlimid. Common interactions include anosmia among females, and diarrhoea among males.
The phase IV clinical study analyzes what interactions people who take Sulfasalazine and Revlimid have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
140 people who take Sulfasalazine and Revlimid together, and have interactions are studied.
What is Sulfasalazine?
Sulfasalazine has active ingredients of sulfasalazine. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 90,768 Sulfasalazine users.
What is Revlimid?
Revlimid has active ingredients of lenalidomide. It is used in multiple myeloma. Currently, eHealthMe is studying from 361,207 Revlimid users.
Number of Sulfasalazine and Revlimid reports submitted per year:
Sulfasalazine and Revlimid drug interactions by gender *:
Sulfasalazine and Revlimid drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Sulfasalazine and Revlimid?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Drug side effects by duration, gender and age:
- Sulfasalazine side effects (90,768 reports)
- Revlimid side effects (361,207 reports)
Common Sulfasalazine drug interactions:
- Sulfasalazine and Methotrexate: 59,101 reports
- Sulfasalazine and Enbrel: 37,279 reports
- Sulfasalazine and Humira: 34,633 reports
- Sulfasalazine and Orencia: 29,235 reports
- Sulfasalazine and Prednisone: 27,457 reports
- Sulfasalazine and Actemra: 26,117 reports
- Sulfasalazine and Leflunomide: 25,760 reports
- Sulfasalazine and Remicade: 22,948 reports
- Sulfasalazine and Plaquenil: 21,432 reports
- Sulfasalazine and Hydroxychloroquine sulfate: 20,790 reports
Browse interactions between Sulfasalazine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Revlimid drug interactions:
- Revlimid and Aspirin: 44,690 reports
- Revlimid and Velcade: 23,355 reports
- Revlimid and Dexamethasone: 21,252 reports
- Revlimid and Gabapentin: 16,507 reports
- Revlimid and Vitamin d: 16,359 reports
- Revlimid and Omeprazole: 15,770 reports
- Revlimid and Amlodipine: 13,230 reports
- Revlimid and Lisinopril: 13,010 reports
- Revlimid and Zometa: 12,392 reports
- Revlimid and Lopurin: 10,125 reports
Browse interactions between Revlimid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on sulfasalazine and lenalidomide (the active ingredients of Sulfasalazine and Revlimid, respectively), and Sulfasalazine and Revlimid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Sulfasalazine and Revlimid.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Fenofibrate and Pyridoxine drug interaction - 4 seconds ago
- Alendronic Acid and Bronchial Secretion Retention - 5 seconds ago
- Orencia and Coumadin drug interaction - 5 seconds ago
- Alendronic Acid and Tivicay drug interaction - 13 seconds ago
- Adcetris and Melaena - 13 seconds ago
- Tricor and Hyponatremia - 13 seconds ago
- Lovenox and Primaquine drug interaction - 18 seconds ago
- Mirabegron and Wellbutrin drug interaction - 19 seconds ago
- Zoloft and Temodar drug interaction - 19 seconds ago
- Pindolol and Miralax drug interaction - 26 seconds ago